Research findings, pricing news, and vendor analysis across the peptide market.
Posts about Tirzepatide
Showing 1 to 11 of 11
There are dozens of online weight loss programs. Most aren't worth your money. We reviewed the ones that are — ranked by pricing, medications, and the support you actually get.
Read more →Compounded tirzepatide commonly costs about $249 to $349 per month through online programs, but the real answer depends on dose, labs, support, and whether brand-name Zepbound cash-pay vials are now the better value. This guide compares the main cost buckets and shows who each option fits.
Read more →Brand Zepbound costs $1,069/month. Compounded tirzepatide starts around $249/month. But is it legit? Here's what real users report and what to look for.
Read more →If your employer drops GLP-1 weight-loss coverage, first separate diabetes coverage from obesity coverage, then confirm denial reasons, appeal if documentation is missing, and compare brand self-pay or vetted telehealth cash-pay options. The fastest backup path is usually a reputable cash-pay program, but the safest choice depends on your drug, diagnosis, budget, and need for FDA-approved medication.
Read more →Without insurance, brand-name GLP-1s cost $12,000–$16,000 per year. Here are real, legal ways to get the same medications for $149–$349/month — no insurance needed.
Read more →The Medicare GLP-1 Bridge starts July 1, 2026 and can bring eligible obesity GLP-1 prescriptions to $50 per month, but only if the patient, indication, drug formulation, prior authorization, and pharmacy claim all line up. Use this checklist to prepare before launch and compare cash-pay backup options if the Bridge does not fit.
Read more →Zepbound can be covered by insurance in 2026, but coverage depends on your plan, formulary, diagnosis, prior authorization rules, and whether the plan treats obesity drugs differently from diabetes drugs. Check benefits first, then compare the Zepbound savings card, LillyDirect self-pay routes, Medicare Bridge timing, Medicaid rules, and cash-pay tirzepatide backup options.
Read more →There is no single official public approved Mounjaro provider list for weight-loss shoppers. This guide explains how to verify legitimate Zepbound and tirzepatide access, compare online providers, and avoid risky sellers before paying.
Read more →CVS Caremark says Zepbound will return to its commercial formularies as an additional preferred option on October 1, 2026, while Lilly's oral GLP-1 Foundayo gets a June 1 coverage path where plans approve it. This guide explains what the change does and does not mean, how to check your own benefits, and when cash-pay or telehealth alternatives still matter.
Read more →Compounded GLP-1s cost a fraction of brand-name Wegovy or Zepbound. But are they the same drug? An honest breakdown of 503A vs 503B pharmacies, what's identical, what's different, and how to decide.
Read more →The Trump administration announced deals with Eli Lilly and Novo Nordisk to significantly reduce the cost of weight loss medications through TrumpRx. Here's what we know and what it means for people taking semaglutide or tirzepatide.
Read more →STOP PIECING IT TOGETHER
We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.
